Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (≥60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMT

Thomas Heinicke*, Myriam Labopin, Emmanuelle Polge, Dietger Niederwieser, Uwe Platzbecker, Henrik Sengelov, Goda Choi, Jan Cornelissen, Didier Blaise, Jürgen Kuball, Gwendolyn van Gorkom, Nicolaas Schaap, Victoria Potter, Franciane Paul, Bipin N Savani, Arnon Nagler, Mohamad Mohty

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)729-739
Number of pages11
JournalBone Marrow Transplantation
Volume55
Issue number4
DOIs
Publication statusPublished - Apr 2020

Keywords

  • VERSUS-HOST-DISEASE
  • ACUTE MYELOID-LEUKEMIA
  • BONE-MARROW-TRANSPLANTATION
  • ANTI-THYMOCYTE GLOBULIN
  • UNRELATED DONORS
  • ANTITHYMOCYTE GLOBULIN
  • HEMATOLOGIC MALIGNANCIES
  • MYELODYSPLASTIC SYNDROME
  • COMPLETE REMISSION
  • CLINICAL-TRIALS

Cite this